Showing results (411-420 of 16,801) with videos related to
Sort By:
Pageof 1,681
British Journal of Haematology|May 19, 2004
Characterisation of Mcl-1 cleavage during apoptosis of haematopoietic cellsJohn G Clohessy, Jianguo Zhuang, Hugh J M BradyBritish Journal of Haematology|May 19, 2004
Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descentG Le Gac, F Mons, S Jacolot, et al.British Journal of Haematology|November 1, 1992
Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblastsS Grant, W D Jarvis, A J Turner, et al.British Journal of Haematology|November 1, 1992
Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcriptsJ Borrow, A D Goddard, B Gibbons, et al.British Journal of Haematology|November 1, 1992
Beta 2-glycoprotein 1 (beta 2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodiesS S Pierangeli, E N Harris, S A Davis, et al.British Journal of Haematology|November 1, 1992
Some 'antiphospholipid antibodies' bind to beta 2-glycoprotein I in the absence of phospholipidD M Keeling, A J Wilson, I J Mackie, et al.British Journal of Haematology|November 1, 1992
Mechanisms of inhibition of T cell IL-2 secretion by factor VIII concentratesM Wadhwa, P Dilger, J Tubbs, et al.British Journal of Haematology|November 1, 1992
Homozygosity for dominant form of hereditary spherocytosisF Duru, A Gürgey, G Oztürk, et al.British Journal of Haematology|May 15, 2004
Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemiaRichard Aplenc, Beverly LangeBritish Journal of Haematology|May 15, 2004
A sensitive model for prediction of relapse in adult acute myeloid leukaemia with t(8;21) using white blood cell count, CD56 and MDR1 gene expression at diagnosisMarkus Schaich, Rainer Koch, Silke Soucek, et al.Pageof 1,681